Abstract
Head and neck carcinomas are initially metastatic in about 15% of cases. Radiotherapy is a cornerstone in the multimodal strategy at the locoregional phase. In patients with head and neck cancer, often heavily pretreated and with comorbidities, who relapse locoregionally or at distant sites, radiotherapy has also become increasingly important at the metastatic phase. Data on the optimal sequence of systemic treatments and metastasis-directed treatments including stereotactic irradiation are still lacking. Several randomized head and neck trials have been initiated that should provide important answers, including one recent GORTEC trial.
Translated title of the contribution | Radiothérapie des cancers épidermoïdes métastatiques de la tête et du cou synchrones ou métachrones oligométastatiques |
---|---|
Original language | English |
Pages (from-to) | 83-92 |
Number of pages | 10 |
Journal | Cancer/Radiotherapie |
Volume | 28 |
Issue number | 1 |
DOIs | |
Publication status | Published - 1 Feb 2024 |
Keywords
- Cancer
- Head and neck
- Oligometastasis
- Radiotherapy
- Squamous cell carcinoma